Tradestie Institutional Equity Comparison Engine

MYCG vs CNAV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CNAV Overall Edge

CNAV Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mohr Company Nav ETF (CNAV) driven by superior Momentum & Technical. Fundamentally, MYCG trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CNAV at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MYCG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNAV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MYCG N/M vs CNAV N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner CNAV
1Y -0.6% vs +14.5% ยท 52W Pos 21% vs 29%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MYCG NASDAQ
SPDR SSGA My2027 Corporate Bond ETF
Institutional Equity
$24.88
+0.04% 1D
Market Cap N/A
1M Return -0.1%
1Y Return -0.62%
Forward P/E N/M
Unified AI Score
53.7 / 100 HOLD
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
CNAV Cboe BZX
Mohr Company Nav ETF
Institutional Equity
$34.32
-1.31% 1D
Market Cap N/A
1M Return -14.49%
1Y Return +14.52%
Forward P/E N/M
Unified AI Score
48.9 / 100 HOLD
Tech 53.0 Fund 49.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MYCG -0.62% CNAV +14.52% Spread: +17.63 pp (CNAV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MYCG TTM Op. Margin: N/A CNAV TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MYCG vs CNAV. Trailing 12-month operating profitability (MYCG N/A vs CNAV N/A) and valuation multiples (MYCG N/M vs CNAV N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MYCG (2) vs CNAV (1)
Institutional Metric MYCG CNAV Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 21% ($25โ€“$25) 29% ($29โ€“$48) Stronger Trend CNAV
Beta / 30D Volatility Risk Regime 0.01ฮฒ ยท 2% Vol 1.69ฮฒ ยท 26% Vol Lower Realized Risk MYCG
Unified Institutional Score Composite Signal 53.7 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite MYCG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MYCG vs CNAV Buy Guide
MYCG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MYCG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CNAV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CNAV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MYCG nor CNAV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.